Yahoo Web Search

  1. To keep the lesson grounded in practicality, we'll use ROE to better understand Merck & Co., Inc. (NYSE:MRK). Our data shows Merck has a return on equity of 33% for ...

  2. Merck & Co., Inc. MRK shares have risen 11.9% this year so far against the industry’s decrease of 2.1%. A significant part of Merck’s outperformance this year so ...

  3. Merck's Keytruda Combination Gets EC Nod for Kidney Cancer

    Zacks via Yahoo FinanceSep 05 13:36 PM

    Merck & Co., Inc. MRK announced that the European Commission has approved the label expansion of its PD-L1 inhibitor, Keytruda, in combination with Pfizer’s PFE Inlyta ( ...

  4. Top Ranked Growth Stocks to Buy for August 27th

    Zacks via Yahoo FinanceAug 27 14:59 PM

    PEG Ratio (TTM) Amdocs Limited peg-ratio-ttm | Amdocs Limited Quote Merck (MRK): This biopharmaceutical company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus ...

  5. Top Ranked Growth Stocks to Buy for August 26th

    Zacks via Yahoo FinanceAug 26 13:01 PM

    Merck & Co., Inc. Price and Consensus Merck & Co., Inc. price-consensus-chart | Merck & Co., Inc. Quote Merck has a PEG ...

  6. Top 6 Holdings of Jeremy Grantham's GMO

    GuruFocus.com via Yahoo FinanceSep 05 22:17 PM

    (NASDAQ:MSFT), Apple Inc. (NASDAQ:AAPL), Oracle Corp. (NYSE:ORCL), UnitedHealth Group Inc. (NYSE:UNH), Medtronic PLC (NYSE:MDT) and Merck & Co. (NYSE:MRK). Grantham ...

  7. Merck (MRK) closed the most recent trading day at $86.05, moving -0.69% from the previous trading session. Coming into today, shares of the pharmaceutical company had gained 2.73% in the past month.

  8. It looks like Merck & Co., Inc. (NYSE:MRK) is about to go ex-dividend in the next 3 days. Merck's next dividend payment will be US$0.55 per share, on the back of ...

  9. Why Is Merck (MRK) Up 4.2% Since Last Earnings Report?

    Zacks via Yahoo FinanceAug 29 13:31 PM

    It has been about a month since the last earnings report for Merck (MRK). Will the recent positive trend continue leading up to its next earnings release, or is Merck due for a ...

  10. Esperion Therapeutics ESPR announced that the phase II study evaluating a combination of pipeline candidate, bempedoic acid, and Merck’s MRK Zetia (ezetimibe) met primary endpoints. The ...

  1. Ads
    related to MERCK & CO., INC